News
Blood clots are a silent threat behind many serious illnesses—from sepsis and cancer to viral infections and autoimmune disease. Now, inventors at the NIH National Cancer Institute (NCI) have identified a promising new way to stop dangerous clots before they spiral out of control, without increasing
Join Steven Ferguson, Deputy Director of Licensing & Entrepreneurship, NIH Office of Technology Transfer, as he speaks at the Innovation Under Pressure series on a variety of technology transfer topics. He is sharing his perspective on technology transfer, licensing and entrepreneurship, and advice
In the United States, one in four cancer deaths occur from lung cancer, however, there is a lack of lung cancer screenings and analysis available quickly and at a low cost. Scientists from the National Cancer Institute’s (NCI) Laboratory of Human Carcinogenesis have proven a unique, non-invasive
The National Cancer Institute’s (NCI) Drug Synthesis and Chemistry Branch created a potential therapeutic for various types of cancers including colon cancer and leukemia by synthesizing a fluorinated cytidine. They showed that incorporating a fluorine atom into the chemical structure of cytidine